Barnard-Kelly Katharine D, Mahoney Edward, Baccari Leah, Oliveria Teresa, Glezer Stanislav, Berard Lori, Morel Didier
Bournemouth University, Dorset, U.K.
BHR Limited, Hampshire, U.K.
Diabetes Spectr. 2021 May;34(2):156-165. doi: 10.2337/ds20-0054. Epub 2021 Dec 22.
Approximately 200 million people worldwide use injectable therapies as part of diabetes management. There appears to be a significant gap between insulin injection technique recommendations and injection practice for many. We aimed to develop and validate a novel, brief, self-administered injection technique assessment questionnaire.
An iterative codesign process was conducted. Focus groups and interviews with adults (or parents of children) with type 1 or type 2 diabetes and health care providers (HCPs) elicited views and refined the tool for broader distribution to the target audience. Questions addressed ease of understanding; relevance; included items and potential missing questions; feelings about diabetes; and any discomfort or judgment felt when completing the tool. A user guide was developed with cognitive interviewing performed to ensure relevance, acceptability, readability, and understanding. Statistical analyses included propensity score matching to identify a subset of the Worldwide Injection Technique Questionnaire with similar characteristics. Boruta feature selection, Cramér's V, and multiple correspondence analysis were conducted.
HCPs and 16 people with diabetes participated in the initial focus groups and interviews. Questions were reported as clinically relevant, simple to complete, "about the right length," relevant, and easy to understand. A total of 267 participants completed the survey reviewing the questionnaire. A further 16 participants underwent cognitive interviews. The complete resource was then reviewed by another 23 people with diabetes as a final check for completeness and usability. Statistical analyses demonstrated high validity and reliability.
This novel resource is clinically relevant, acceptable, and easy to use as both a clinical tool and a self-assessment tool for people using injectable therapies for diabetes.
全球约有2亿人使用注射疗法作为糖尿病管理的一部分。对许多人来说,胰岛素注射技术建议与注射实践之间似乎存在显著差距。我们旨在开发并验证一种新颖、简短、可自行管理的注射技术评估问卷。
进行了迭代式协同设计过程。对1型或2型糖尿病成人患者(或儿童家长)以及医疗保健提供者(HCPs)进行焦点小组讨论和访谈,以收集意见并完善该工具,以便更广泛地分发给目标受众。问题涉及易于理解程度、相关性、包含的项目和可能遗漏的问题、对糖尿病的感受以及填写该工具时的任何不适或评判感。制定了用户指南,并进行了认知访谈以确保相关性、可接受性、可读性和理解性。统计分析包括倾向得分匹配,以识别具有相似特征的全球注射技术问卷子集。进行了Boruta特征选择、克莱默V系数分析和多重对应分析。
HCPs和16名糖尿病患者参与了最初的焦点小组讨论和访谈。据报告,问题具有临床相关性、易于完成、“长度合适”、相关且易于理解。共有267名参与者完成了对问卷的调查评审。另外16名参与者接受了认知访谈。然后,另外23名糖尿病患者对完整资源进行了最终检查,以确保完整性和可用性。统计分析表明该问卷具有高有效性和可靠性。
这种新颖的资源具有临床相关性、可接受性,并且作为临床工具和糖尿病注射疗法使用者的自我评估工具都易于使用。